Offering prophylactic treatment before immunotherapy could significantly reduce the rate of cytokine release syndrome in multiple myeloma patients, a new US study has found.
Treatment breakthroughs, such as the immunotherapy drug teclistamab, can...
1 year ago
A major new study will assess if a beta blocker used to treat heart problems, haemangioma, migraines, and anxiety would benefit sickle cell disease patients, it has been announced.
Researchers at Indiana University School of Medicine, USA, have be...
1 year ago
